NZ Multiple Myeloma Research Review Issue 2

In this issue:

8q24 region variations and MM risk
Low- vs. high-dose thalidomide for advanced MM
Prognostic value of PINI
Lenalidomide maintenance after SCT
Complex karyotype and t(4;14) identifies high risk
Prognosis based on adverse FISH lesions and ISS
Bortezomib before and after SCT improves
MM with del(17p13)
HCO haemodialysis + chemotherapy in MM with AKI
Bendamustine in relapsed/refractory MM

Please login below to download this issue (PDF)

Subscribe